Baxter received regulatory approval to introduce its HOMECHOICE CLARIA automated peritoneal dialysis (APD) system to the European market. Designed for home use, the device was made for ease of use and it works with Baxter’s SHARESOURCE online platform that allows clinicians to review patients’ dialysis sessions. Thanks to this feature, patients don’t have to keep journals and clinics don’t have to bother creating reports from those journals, since all that is done automatically.
The readout on the device itself can be set to work with any of 41 pre-programmed languages, allowing it to be used in different markets around the world. Baxter will soon begin introducing the system both in Europe and certain Asian countries.
More from Baxter…
